Abivax S.A.
$117.93
+1.78 (+1.53%)
Price as of Aug 25, 2026 market close
Performance
- 1 Month
- -7.9%
- 3 Months
- -6.7%
- YTD
- -12.6%
- 1 Year
- +52.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 85.0%
- Largest decline max drawdown, since Aug 2025
- -50.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.95
Own ABVX?
See how ABVX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.